Awareness of Individuals with Chronic Lung Disease About Climate Change, Heat Waves, Air Pollution and Physical Activity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHacettepe University
About this trial
Climate change is characterized by global temperature increase, melting of glaciers and increasing temperature of ocean waters. Increase in greenhouse gases such as nitrogen and carbon dioxide negatively affects air and water quality. Extreme events such as extreme heat waves, floods and hurricanes are events seen with climate change. It is known that climate change and air pollution have negative effects on public health. Its adverse effects are often seen in individuals with rhinosinusitis, asthma and chronic obstructive pulmonary disease. Air pollution is expected to increase due to the ongoing economic growth and population growth worldwide, resulting in more respiratory diseases and disease burden. This study aims to assess the awareness level of individuals with chronic lung disease on climate change, heat waves, air pollution and their interaction with physical activity and anxiety and depression levels, and to better understand the experiences of patients and learn their perspectives. Within the scope of the study, it is planned to provide patients brief information on this subject and receive feedback about this information.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being 18 years of age or older,
Having a chronic lung disease (COPD, asthma, bronchiectasis, cystic fibrosis, interstitial lung disease) and being referred to the Cardiopulmonary Rehabilitation Unit of Hacettepe University, Faculty of Physical Therapy and Rehabilitation for cardiopulmonary physiotherapy and rehabilitation,
Being clinically stable,
Using a smartphone with a pedometer,
Disqualifiers
Having had an acute exacerbation or having changed medication in the last month,
Having a severe cardiovascular, orthopedic or neurological problem that may affect the tests.
Trial population
Having a chronic lung disease (COPD, asthma, bronchiectasis, cystic fibrosis, interstitial lung disease)
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
80 Participants
are divided into 4 treatment groupsGroup A: Individuals with chronic obstructive lung disease1 intervention
Group B: Individuals with asthma1 intervention
Group C: Individuals with bronchiectasis1 intervention
Group D: Individuals with interstitial lung disease1 intervention
Trial outcomes
Primary outcomes
1
Air temperature
The air temperature of the province and district where the patients were located and lived one week before the assessment will be recorded from the open access website of the General Directorate of Meteorology of the Ministry of Environment and Urbanization (https://www.mgm.gov.tr/).
Time frame
1 week before other assessments2
Humidity level
The humidity level of the province and district where the patients were located and lived one week before the assessment will be recorded from the open access website of the General Directorate of Meteorology of the Ministry of Environment and Urbanization (https://www.mgm.gov.tr/).
Time frame
1 week before other assessments3
Wind speed
The wind speed of the province and district where the patients were located and lived one week before the assessment will be recorded from the open access website of the General Directorate of Meteorology of the Ministry of Environment and Urbanization (https://www.mgm.gov.tr/).
Time frame
1 week before other assessments4
Air pollution
The province and district where the patients were located and lived in the last week before the assessment will be recorded and the air pollutant values of PM2.5, PM10, CO, NO2, SO2, NO, O3 in the settlement where they lived in the last week will be accessed from the open access website of the continuous monitoring center of the Ministry of Environment and Urbanization and will be recorded and used for analysis. (https://sim.csb.gov.tr/STN/STN\_Report/StationDataDownloadNew).
Time frame
1st daySecondary outcomes
1
Respiratory functions
Respiratory function test values will be recorded from patient records.
Time frame
1st day2
Body mass index
Body mass index value will be calculated.
Time frame
1st day3
Disease-related symptoms
Disease-related symptoms (shortness of breath, cough and sputum) will be questioned and recorded.
Time frame
1st day4
Socio-economic status
Socio-economic status will be recorded.
Time frame
1st daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov